1. Home
  2. PTON vs TLX Comparison

PTON vs TLX Comparison

Compare PTON & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peloton Interactive Inc.

PTON

Peloton Interactive Inc.

HOLD

Current Price

$5.06

Market Cap

2.6B

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$10.75

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTON
TLX
Founded
2012
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
PTON
TLX
Price
$5.06
$10.75
Analyst Decision
Buy
Strong Buy
Analyst Count
13
4
Target Price
$8.05
$21.13
AVG Volume (30 Days)
14.3M
231.9K
Earning Date
05-07-2026
08-19-2026
Dividend Yield
N/A
N/A
EPS Growth
80.13
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.44
N/A
P/E Ratio
N/A
$150.33
Revenue Growth
N/A
N/A
52 Week Low
$3.65
$6.28
52 Week High
$9.20
$19.93

Technical Indicators

Market Signals
Indicator
PTON
TLX
Relative Strength Index (RSI) 66.57 69.28
Support Level $4.09 $10.60
Resistance Level $6.97 $11.18
Average True Range (ATR) 0.33 0.33
MACD 0.08 0.08
Stochastic Oscillator 93.95 71.73

Price Performance

Historical Comparison
PTON
TLX

About PTON Peloton Interactive Inc.

Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product derives revenue from the portfolio of Connected Fitness Products and related accessories, as well as Precor-branded fitness products, delivery and installation services, Peloton Bike portfolio rental products, extended warranty agreements, branded apparel, and commercial service contracts. Subscription revenue is derived from monthly Subscription fees. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from International markets.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: